R É S U M É

Doc. MVDr. Tomáš Sládek, CSc.

Vice President and Chief Scien­tific Officer of MEDEA PHARM s.r.o.

 

EDUCATION

 

Doc.

Habilitation

3/17/1994

Academic degree corresponding to Asso­ciate Professor of Physiology and Patho­physiology

 

Medical Faculty

Masaryk University

662 43 Brno

CSc. (corresp. to Ph.D.)

diploma

3/15/1985

Postgraduate course of supervised research

(12/79 - 3/85)

University of Veterinary Medicine

Palackého Str. 1/3

Brno

MVDr. (corresp. to M.V.D.)

diploma

3/25/1972

 

 

University level

(10/66 - 3/72)

 

University of Veterinary Medicine

Palackého street 1/3

Brno

 

WORK EXPERIENCE

 

Vice President and Chief Scientific Officer of MEDEA PHARM s.r.o.

07/1999 – present

 

 

Srbská 46

612 00 Brno

 

Programme Manager, Depart­ment of  Technical Strategy

05/1998 – 02/1999

Headquarters

LACHEMA, a.s.

Karásek 1

Brno

Head of Department of Clinical Pharma­cology

10/1995 - 04/1998

 

Headquarters

LACHEMA, a.s.

Karásek 1

Brno

 

Associate Professor

3/1994 - 10/1995

 

Inst. Pathol. Physiol.

Medical Faculty

Masaryk University

662 43 Brno

 

Visiting Scientist

award from East Eur. Exchange Program of MRC of Canada

1/93 - 12/93

Dept. Physiol. Medical Faculty

University of Ottawa

451 Smyth Road

Ottawa, K1H 8M5 Ont.

Canada

 

Senior Lecturer

10/1990 - 3/1994

 

Inst. Pathol. Physiol. Medical Fac­ulty

Masaryk University

662 43 Brno

 

Part-time Expert

10/1990 - 12/1991

 

 

Research Institute of Fine Chemi­cals LACHEMA n.e.

Karásek 1

621 33 Brno

Head of Department of Pharma­cology and Toxicology

 

10/1985 - 9/1990

Research Institute of Fine Chemi­cals LACHEMA n.e.

Karásek 1

621 33 Brno

 

Operating Room Manager

1/1975 – 12/1979

 

 

Artificial Heart Research Center of the Regional Institute of Health affiliated to the Medical Faculty of Masaryk University in Brno

 

Research Fellow (experimental surgery

8/1972 - 9/1985

Artificial Heart Research Center of the Regional Institute of Health affiliated to the Medical Faculty of Masaryk University in Brno

 

 

MEMBERSHIP IN ACADEMIC BODIES AT MASARYK UNIVERSITY

 

 

 
PUBLICATIONS
 

Full Length Papers:

79

Patents:

2

Number of Citations:

148

 

LIST OF THE MOST IMPORTANT PUBLICATIONS

 

1.       

Sladek T, Sladkova J, Kolar F, Papousek F, Cicutti N, Korecky B, Rakusan K. The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats. Cardiovasc Res 1996;31:568–576. [№. of citations: 47] Abstract Free Full Text

2.       

Sladek T, Gerova M, Znojil V, Devat L. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res 1996;45(4):335 –338. [№. of citations: 33] Abstract

3.       

Rakusan K, Cicutti N, Sladek T. Ischemic heart: microcirculatory aspects. Adv Exp Med Biol 1996;388:457–461.

4.       

Filkuka J, Sladek T, Kleinwächter V, Neuhybel P, Hofirek B, Kiss F. Study of chronic toxicity of calcium antagonist diltiazem (BLOCALCIN 60 Lachema): Histopathological study on Beagle dogs. Scripta med. 1990;63:463–470.

5.       

Juraskova V, Sladek T. Antimetastatic activity of diltiazem on LS/BL tumor cells in liver-tumor-colony assay. Neoplasma 1990;37:343–347. [№. of citations: 4] Abstract

6.       

Dostal M, Vasku J, Dolezel S, Pavlicek V, Necas J, Sladek T. [The effect of reperfusion and diltiazem on the extent of experimental infarct in the dog]. Cesk. Fysiol. 1989;38(6):561–564.

7.       

Kostal M, Rajcani J, Sladek T. [Treatment of mice infected with herpes simplex viruses using acycloguanosine]. Bratisl Lek Listy 1988;89(7):495–503.

8.       

Salamoun J, Sprta V, Sladek T, Smrz M. Determination of acyclovir in plasma by column liquid chromatography with fluorescence detection. J Cromatogr Biomed Appl 1987,420:197–202. [№. of citations: 25]

9.       

Dolezel S, Gerova M, Hartmannova B, Sladek T, Dostal M, WENDSCHE P, JANECKOVA H, Vasku J. Adrenerge Innervation des Hundeherzens nach einseitiger Sympathektomie, Verh Anat Ges 1986;80:555–557.

10.   

Dolezel S, Vasku J, Hartmannova B, Filkuka J, Cerny J, Dostal M, Sladek T, Urbanek E. Innervation of atrial stumps in calves living with the TNS-Brno II artificial heart. Artif. Organs 1985;9(1):53–58. Abstract

11.   

Sladek T, Filkuka J, Dolezel S, Vasku J, Hartmannova B, Travnickova J. The border zone of the early myocardial infarction in dogs: its characteristics and viability. Basic Res Cardiol 1984;79:344–349. [№. of citations: 6] Abstract

12.   

Trbusek V, Fiala V, Vrbova M, Urbanek P, Vasku J, Urbanek E, Pavlicek V, Sotolova O, Dostal M, Sladek T. The heart prosthesis – biocompatibility with living tissue [letter]. Int J Artif Organs 1984;7:163–164.

13.   

Hartmannova B, Vasku J, Dolezel S, Urbanek E, Filkuka J, Sladek T, Krcek L, Guba P, Dostal M, Cerny J. Mechanisms causing the death of 8 calves surviving with implanted artificial heart from 31 to 173 days. Exp Pathol 1984;26:221–225. Abstract

14.   

Vasku J, Cerny J, Urbanek E, Dostal M, Urbanek P, Guba P, Pavlicek V, Sladek T Smutny M. A comparative study of a group of eight calves, surviving longer than 1 month with the total artificial heart. Artif Organs 1983;7(4): 470–478. [№. of citations: 3] Abstract

15.   

Dostal M, Vasku J, Cerny J, Guba P, Pavlicek V, Sladek T, Janeckova H, Sotolova O, Urbanek E. Some problems associated with the implantation of a cardiac prosthesis and with early postoperative care in animals with a total artificial heart. Life Support. Syst 1983;1:281–290. Abstract

16.   

Dolezel S, Sladek T, Vasku J. [Histochemical aspects of experimental myocardial infarct in relation to sympathetic innervation]. Cesk Fysiol 1982;31(6):571–576.

17.   

Vasku J, Cerny J, Hanzelka P, Urbanek E, Dostal M, Urbanek P, Guba P, Pavlicek V, Krcek L, Sladek T, Hartmannova B, Filkuka J, Janeckova H, Sotolova O, Sotakova E, Dolezel S, Krcma V, Cidl K, Bednarik B. 150-day survival of a calf with a polymethylmethacrylate total artificial heart: TNS-BRNO-II. Artif Organs 1981;5(4):388–400. [№. of citations: 1]

18.   

Cerny J, Vasku J, Dostal M, Gregor Z, Hanzelka P, Wendsche P, Sladek T, Guba P, Pavlicek V, Sotolova O, Urbanek E, Urbanek P, Krcek L, Janeckova H, Sotakova E, Hartmannova B, Dolezel S. [Surgical aspects of artificial heart implantation]. Rozhl Chir 1981;60:354–360.

19.   

Sladek T, Vasku J, Urbanek E, Filkuka J, Dolezel S, Wendsche P, Hartmannova B, Sotolova O. Reperfusion of coronary arteries after temporary occlusion in dogs. J Cardiovasc Surg (Torino) 1980;21(6):695–702. Abstract

20.   

Dolezel S, Gerova M, Gero J, Sladek T, Vasku J. Monoaminergic pathways to the coronary arteries and to the myocardium.  Acta Anat (Basel) 1980;108:490–7. [№. of cit.: 3] Abstract

21.   

Vasku J, Cerny J, Hanzelka P, Vasku Jan, Urbanek E, Dostal M, Urbanek P, Guba P, Pavlicek V, Krcek L, Sladek T, Hartmannova B, Filkuka J, Janeckova H, Sotolova O, Sotakova E, Dolezel S, Krcma V, Cidl K, Bednarik B. The 150-day survival of a calf with the polymetyl matacrylate total artificial heart – TNS BRNO – II. Artificial Organs 1980;5:388–400.

22.   

Dolezel S, Gerova M, Gero J, Sladek T, Vasku J. Adrenergic innervation of the coronary arteries and the myocardium. Acta Anat 1978;100:306–316. [№. of cit.: 26] Abstract

23.   

Sladek T, Filkuka J, Pejchlova M, Sotolova O, Hartmannova B, Vitek J, Dostal M, Stepanek V, Urbanek E, Vasku J, Bednarik B. Suppression of the progress of necrosis after coronary artery ligation in the dog by pharmacologic interventions. J Cardiovasc Surg (Milano) 1976;17:321–328. Abstract